Glycos Biotechnologies

2450 Holcombe Boulevard Suite J-510
Houston, Texas, 77021

Richard Clientele(CEO)

Business Description :

Glycos Biotechnologies, Inc., a food science and biotechnology company, develops and produces personalized nutritional foods for dietary deficiencies in individuals with varying health conditions. It offers Monomega, a pre-digested monoglyceride form of the essential omega-3 fatty acids the body needs for cell growth and cell maintenance; Monomega-V, which combines the high performance delivery of essential fatty acids with essential vitamins; and Peptide Plus, which provides plant-based hypoallergenic protein hydrolysates (pre-digested peptide blends) tuned for peptide size and personalized gut functions. The company was founded in 2007 and is based in Houston, Texas.